Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting

In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine

(2017) Shu Li et al.   International Journal of Nanomedicine

Lung regeneration using amniotic fluid mesenchymal stem cells

(2017) Alireza Azargoon et al.   Artificial Cells Nanomedicine and Biotechnology

In vitro expansion of CD 133+ cells derived from umbilical cord blood in poly-L-lactic acid (PLLA) scaffold coated with fibronectin and collagen

(2017) Maryam Islami et al.   Artificial Cells Nanomedicine and Biotechnology

Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma

(2017) Kasper Bendix Johnsen et al.   Scientific Reports

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Progression and metastasis of lung cancer

(2016) Helmut H. Popper   CANCER AND METASTASIS REVIEWS

New and emerging targeted treatments in advanced non-small-cell lung cancer

(2016) Fred R Hirsch et al.   LANCET

Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells

(2016) Jie Gao et al.   Nanomedicine

Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line

(2016) Öznur Akbal et al.   Artificial Cells Nanomedicine and Biotechnology

Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system

(2016) Fang-Yuan Xie et al.   World Journal of Gastrointestinal Oncology

Novel pH-sensitive nanoformulated docetaxel as a potential therapeutic strategy for the treatment of cholangiocarcinoma

(2015) Nan Du et al.   JOURNAL OF NANOBIOTECHNOLOGY

First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer

(2013) G. M. Blumenthal et al.   CLINICAL CANCER RESEARCH

RNA aptamers targeting cancer stem cell marker CD133

(2012) Sarah Shigdar et al.   CANCER LETTERS

Lung cancer stem cells: Progress and prospects

(2012) Amber Lundin et al.   CANCER LETTERS

The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes

(2011) Jie Gao et al.   BIOMATERIALS

Aptamers as therapeutics

(2010) Anthony D. Keefe et al.   NATURE REVIEWS DRUG DISCOVERY

Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing

(2009) Jie Gao et al.   BIOMATERIALS

Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs

(2009) H A Burris   ONCOGENE

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

(2009) G. Bertolini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA